UniQuest Revenue and Competitors

UniQuest is the main commercialisation company of The University of Queensland (UQ), specialising in the commercialisation of intellectual property, research outcomes and expertise. Established in 1984, UniQuest is one of the oldest, largest and most successful commercialisation groups in Australia. UniQuest manages an extensive intellectual property estate that has given rise to more than 1,000 industry partnerships, over 140 technologies licensed and more than 40 active start-up companies. UniQuest has raised more than $450 million to take UQ technologies to market, with UniQuest-licensed UQ innovations generating gross product sales of more than US$10 billion to date. UniQuest's innovation portfolio includes Australia's first blockbuster vaccine Gardasil®, Australia's largest biotech IPO (QRxPharma Ltd), the internationally acclaimed Triple P Positive Parenting Program, and UQ's image correction technology, used in two-thirds of the world's magnetic resonance imaging (MRI) machines. Intellectual Property Commercialisation, ilab start-up business incubator and accelerator, Consulting and Contract Research, Industry Engagement